These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 33085005)

  • 1. Public perceptions on Controlled Human Infection Model (CHIM) studies-a qualitative pilot study from South India.
    Vaz M; Timms O; Johnson AR; S RK; Ramanathan M; Vaz M
    Monash Bioeth Rev; 2021 Jul; 39(1):68-93. PubMed ID: 33085005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing public perception of a sand fly biting study on the pathway to a controlled human infection model for cutaneous leishmaniasis.
    Parkash V; Jones G; Martin N; Steigmann M; Greensted E; Kaye P; Layton AM; Lacey CJ
    Res Involv Engagem; 2021 May; 7(1):33. PubMed ID: 34053461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions about controlled human infection model (CHIM) studies among members of ethics committees of Indian medical institutions: A qualitative exploration.
    Sharma A; Apte A; Rajappa M; Vaz M; Vaswani V; Goenka S; Malhotra S; Sangoram R; Lakshminarayanan S; Jayaram S; Mathaiyan J; Farseena K; Mukerjee P; Jaswal S; Dongre A; Timms O; Shafiq N; Aggarwal R; Kaur M; Juvekar S; Sekhar A; Kang G
    Wellcome Open Res; 2022; 7():209. PubMed ID: 36969719
    [No Abstract]   [Full Text] [Related]  

  • 4. Public engagement in the context of a CHIM study.
    Vaz M
    Indian J Med Ethics; 2018; 3(4):296-300. PubMed ID: 30683641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conducting controlled human infection model studies in India is an ethical obligation.
    Dholakia SY
    Indian J Med Ethics; 2018; 3(4):263-266. PubMed ID: 30474610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public communication about CHIM: What is the role of the media?
    Srinivasan S
    Indian J Med Ethics; 2018; 3(4):301-304. PubMed ID: 30683642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typhoidal Salmonella human challenge studies: ethical and practical challenges and considerations for low-resource settings.
    Raymond M; Gibani MM; Day NPJ; Cheah PY
    Trials; 2019 Dec; 20(Suppl 2):704. PubMed ID: 31852488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consultation on the feasibility and ethics of specific, probable Controlled Human Infection Model study scenarios in India: A report.
    Vaz M; Timms O; Rose A; Manesh A; Bhan A
    Indian J Med Ethics; 2019; 4(3):238-242. PubMed ID: 31213422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Payment in challenge studies: ethics, attitudes and a new payment for risk model.
    Grimwade O; Savulescu J; Giubilini A; Oakley J; Osowicki J; Pollard AJ; Nussberger AM
    J Med Ethics; 2020 Dec; 46(12):815-826. PubMed ID: 32978306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioethics of establishing a CHIM model for dengue vaccine development.
    Rose A; Sekhar A
    Int J Infect Dis; 2019 Jul; 84S():S74-S79. PubMed ID: 30641207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consultations on human infection studies in India: Do people's voices really count?
    Srinivasan S; Johari V
    Indian J Med Ethics; 2019; 4(3):234-237. PubMed ID: 31213425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expert voices and equal partnerships: establishing Controlled Human Infection Models (CHIMs) in Vietnam.
    Kestelyn E; Le Phuong C; Ilo Van Nuil J; Dong Thi HT; Minh Nguyen N; Dinh The T; Chambers M; Simmons CP; Nguyen Trong T; Nguyen The D; Phuong LT; Do Van D; Duc Anh D; Nguyen Van VC; Baker S; Wills B;
    Wellcome Open Res; 2019; 4():143. PubMed ID: 31681857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ethics of volunteer selection and compensation in Controlled Human Infection Models in India.
    Rose A
    Indian J Med Ethics; 2018; 3(4):285-289. PubMed ID: 30683638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What risks should be permissible in controlled human infection model studies?
    Binik A
    Bioethics; 2020 May; 34(4):420-430. PubMed ID: 32115747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involving South Asian patients in clinical trials.
    Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
    Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative analysis of vaccine decision makers' conceptualization and fostering of 'community engagement' in India.
    Dutta T; Meyerson BE; Agley J; Barnes PA; Sherwood-Laughlin C; Nicholson-Crotty J
    Int J Equity Health; 2020 Oct; 19(1):185. PubMed ID: 33081792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders.
    Chi PC; Owino EA; Jao I; Olewe F; Ogutu B; Bejon P; Kapulu M; Kamuya D; Marsh V;
    Trials; 2021 Jul; 22(1):494. PubMed ID: 34311781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cashless childbirth, but at a cost: A grounded theory study on quality of intrapartum care in public health facilities in India.
    Jha P; Christensson K; Svanberg AS; Larsson M; Sharma B; Johansson E
    Midwifery; 2016 Aug; 39():78-86. PubMed ID: 27321724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third human challenge trial conference, Oxford, United Kingdom, February 6-7, 2020, a meeting report.
    Pollard AJ; Sauerwein R; Baay M; Neels P;
    Biologicals; 2020 Jul; 66():41-52. PubMed ID: 32505512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.